How much funding has NeuroQore, Inc. raised?

NeuroQore, Inc. has raised $1.8M in total funding, most recently a Seed round.

Who are NeuroQore, Inc.'s investors?

NeuroQore, Inc.'s investors include IndieBio, SOSV.

When was NeuroQore, Inc. founded?

NeuroQore, Inc. was founded in 2012.

Where is NeuroQore, Inc. headquartered?

NeuroQore, Inc. is headquartered in Mountain View, California, United States.

What industry is NeuroQore, Inc. in?

NeuroQore, Inc. operates in Biotech, Healthcare.

How many employees does NeuroQore, Inc. have?

NeuroQore, Inc. has 1-10 employees.

NeuroQore, Inc.

Pioneering neuromodulation for depression and suicidality

Mountain View, United States · Founded 2012 · $1.8M raised

Biotech

Healthcare

Headquarters: Mountain View, California
Employees: 1–10
Founded: 2012
Business Model: B2B

Website: neuroqore.com
Total Funding: $1.8M
Last Round: $250K SeedSep 2025
Rounds: 2

About

NeuroQore is a neuromodulation medtech company developing breakthrough rapid treatments for major depressive disorder and treatment-resistant depression using magnetic pulse technology. The company collaborates with world-class universities and research clinics to create non-pharmacological alternatives to electroconvulsive therapy for acutely suicidal patients.

Summary

NeuroQore, Inc. is a Biotech company based in Mountain View, United States, founded in 2012. It has raised $1.8M in total across 2 rounds, most recently a $250K Seed round in Sep 2025. Investors include IndieBio and SOSV.